title: Malignant mixed mesodermal tumor of the ovary treated with a cisplatin-irinotecan combination: case report.
authors.affiliation: Multidisciplinary Gynecologic Cancer Center, The University of Texas, M.D. Anderson Cancer Center, Houston Texas 77030, USA.
authors.forename: P
authors.initials: P
authors.lastname: Azevedo
authors.forename: C F
authors.initials: CF
authors.lastname: Verschraegen
authors.forename: J J
authors.initials: JJ
authors.lastname: Kavanagh
authors.forename: A P
authors.initials: AP
authors.lastname: Kudelka
authors.forename: R S
authors.initials: RS
authors.lastname: Freedman
authors.forename: K
authors.initials: K
authors.lastname: Lu
authors.forename: M T
authors.initials: MT
authors.lastname: Deavers
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D002945:Cisplatin / Q000008:administration & dosage; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D005260:Female; D006801:Humans; D000077146:Irinotecan; D008875:Middle Aged; D018199:Mixed Tumor, Mesodermal / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D012074:Remission Induction; D059004:Topoisomerase I Inhibitors
chemical_list: D004791:Enzyme Inhibitors; D059004:Topoisomerase I Inhibitors; D000077146:Irinotecan; D002945:Cisplatin; D002166:Camptothecin